TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in total fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Root-mean-square of device SpO2 measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Root-mean-square of device Pulse Rate measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elevated troponin T levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Omega 3 index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Asthma Control Questionnaire 7 (ACQ-7) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Naloxone administration skill
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement between eye-tracking biomarker score and diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of repeat pulmonary vein isolation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with clinical relapses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival prediction
Endpoint domain: Mortality/survival
Primary endpoint: Same Day Discharge Rate
Endpoint domain: Resource use
Primary endpoint: Readmission Rate
Endpoint domain: Resource use
Primary endpoint: Rate of presentation to the emergency room after surgery
Endpoint domain: Resource use
Primary endpoint: Change from baseline Internet gaming disorder (IGD) immediately after the interventions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Internet gaming disorder (IGD) at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratio of predicted neoantigens being presented by HLA-I
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Ratio of predicted neoantigens being immunogenic
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Presence - absence of predisposing mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Left ventricular outflow tract pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of subjects experiencing a CRS or an ICANS
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of infections, leukopenia and/or hypogammaglobulinemia
Endpoint domain: Adverse events/effects
Primary endpoint: Epidemiological and clinical characteristics of patients with Heart Failure with reduced ejection fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Area under the etavopivat plasma concentration-time curve (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed etavopivat plasma concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pouch Function Score (PFS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Program Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safe Sex
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Desires for alcohol questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in Haemoglobin (Hb) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Patient-reported acute urinary toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Anxiety and depression control
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Geriatry Depression Scale (GDS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Resourcefulness Scale
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Spiritual Health/Spiritual Self-assessment index for older adult
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients reporting binge drinking episodes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Stage 3 Acute Kidney Injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Rate of minimal residual disease (MRD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of Adverse Event of Special Interest (AESIs)
Endpoint domain: Adverse events/effects
Primary endpoint: CMV lgG, lgM positive rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CMV lgG, lgM antibody titer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in the MDS-UPDRS - part II
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resumption of menses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved clinical hormone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Efficacy after CM313/Placebo treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with significant genetic variants identified
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ROM Elbow (Flexion)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ROM Elbow (Extension)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ROM Forearm (Supination)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ROM Forearm (Pronation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of ADRs during use of Forxiga
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of unexpected ADRs
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in Worst Itch Numerical Rating Scale (WI-NRS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of grade ≥3 infusion-related Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of acute Graft Vs Host Disease (aGVHD) grade ≥3
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Systemic Inflammatory Response Syndrome (SIRS) or CRS
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Multi-System Inflammatory Syndrome (MIS)
Endpoint domain: Adverse events/effects
Primary endpoint: Time to First Smoking Lapse
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients taking antibiotics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Auditory Cognition
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Child Duration of Joint Attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parent Fidelity of Implementation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in somatosensory responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in bite force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in epistaxis duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International Physical Activity Score (short form) MEt-min/week
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mineral Density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Average anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Chronic stress levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Osteoporosis Knowledge Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Osteoporosis Health Belief Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Post-cardiac arrest survival
Endpoint domain: Mortality/survival
Primary endpoint: Neurological outcome - GCS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neurological outcome - CPC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Eligibility to randomization ratio
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Weekly recruitment rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adherence to Egg pudding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Characterisation of genes in appendiceal cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: PWUD's STTR fulfillment score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adherence (Level of engagement with the treatment [percentage])
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PrEP interest
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PrEP linkage
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Euro Qol (EQ-5D-5L)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pharmacokinetics of Total Radioactivity in Blood and Plasma (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics of Total Radioactivity in Blood and Plasma (AUC-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics of Total Radioactivity in Blood (T1/2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annualised asthma exacerbation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of gastric venous congestion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of gastric ischemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Colony Forming Units
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: State-Trait Anxiety Inventory Difference
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: risk of overweight and/or obesity in children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Target population recruitment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Fidelity to intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability by intervention participants
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in spine bone marrow fat content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in hip bone marrow fat content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation of changes in spine bone marrow fat content with changes in spine bone strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in Pregnancy Unique Quality of Emesis (PUQE) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in monocyte phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IBS Specific Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality Adjusted Life Years
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean Change From Baseline in Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Anti-tumor effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: short-term efficacy of chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: long-term efficacy of chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Lip Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Modified Severity Weighted Assessment Tool (mSWAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of respiratory failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Successful Implantation of the ThecaFlex DRx™ Port and Catheter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Successful Intrathecal Therapy Infusion(s) through 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Forward Head Posture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reach discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Amount of Luteinizing hormone Surge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Traumatic stress symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with adverse events (AEs) meeting protocol-defined Dose-Limiting Toxicity (DLT) criteria
Endpoint domain: Adverse events/effects
Primary endpoint: Immune cell composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Monocyte phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Functional and Metabolic characteristics of monocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes of iris neovascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Best Complete Response (CR), Complete Response with Incomplete Blood Count Recovery (CRi), Complete Response with Partial Hematologic Recovery (CRh)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of peripheral neuropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percent of Participant Adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percent of Participant Retention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mini mental state examination
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: SCFAs levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Beta-Endorphin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypocretin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference of maximal voluntary contraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of urinary and serum biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Diaphragmatic thickness and thickening fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Diaphragm movement curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total radioactivity in plasma PK
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total radioactivity in urine and fecal samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolite G1T30 and other major metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of ARDA mtmDR for detection of mtmDR in 45 degree images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of ARDA mtmDR for detection of mtmDR in 45 degree images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of ARDA mtmDR for detection of mtmDR in UWF images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of ARDA mtmDR for detection of mtmDR in UWF images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: residual urine volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of patients categorized into triage categories by Triage Nurse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients categorized into triage categories by ER Physician
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3-month rehospitalization
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Agreement for FEV1 measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rates of enrollment and percentage of eligible patients enrolled
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of participants completing all study visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Western Ontario McMaster University Osteoarthritis Index (WOMAC)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Predictive Accuracy of Sagittal Height for Scleral Lens Fit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of articles published in indexed journals
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Quartile of journals for published articles
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Short Chain Fatty Acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glucagon Like Peptide Hormone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: changes in the expression of CD184(CXCR4) in circulating B cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Need for physician epidural top-up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in weekly mean of average pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in upper limb use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose of exercise received
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achievement of vIGA-AD 0/1 at Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Achievement of EASI 75 at Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change from Baseline in pain on Numeric Pain Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Goniometer readings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from baseline in Neck disability index questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Heart failure of cardiac dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Oral food challenge threshold to peanut
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in insulin antibody titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in frequency of B cells within total PBMC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in inflammatory Index by serum transcriptional exposure assay
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Prevalence of sexual dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Gestational latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Square wave jerks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Horizontal saccades abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Vertical saccades abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Smooth pursuit abnormality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Antisaccade abnormality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Functional Performance Assessment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in 6-minute walk tests (6-MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: King's Brief Interstitial Lung Disease Questionnaire (K-BILD) score change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percent weight lost at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: minimal residual disease (MRD) status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with Participation
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Liver steatosis severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes